8 results
Classic Digoxin-Associated Arrhythmias
 • Atrial fibrillation with an unusually slow ventricular response
 • Atrial Fibrillation with
Classic Digoxin-Associated ... Arrhythmias • ... unusually slow ventricular ... Bidirectional Ventricular ... #cardiology #ecg
Almost any type of cardiac arrhythmia is seen in digitalis toxic­ity. However, type II second-degree atrioventricular
type of cardiac arrhythmia ... The arrhythmias ... Non-paroxysmal atrial ... #Diagnosis #Cardiology ... #EKG #ECG #Digoxin
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
Common Sustained Arrhythmia ... (< 5% pts with afibb ... disease, left ventricular ... thrombus • Digoxin ... diagnosis #management #cardiology
Palpitations - Differential Diagnosis Framework

What?
• It is an unpleasant awareness or sensation that the heart is
exam • 12-lead ECG ... supraventricular or ventricular ... tachycardia • Ventricular ... /Afib/WPW) • Loss ... #Palpitations #Cardiology
Premature Ventricular Complexes (PVC's) - Summary Framework

Why PVCs?  Can be the first manifestation of cardiac
Cardiomyopathy • Inherited arrhythmia ... Substances • Digoxin ... capture of the atria ... • Atrial fibrillation ... #differential #cardiology
Ventricular Fibrillation on POCUS - Apical 4 Chamber View

A 50-year-old woman with a history of cardiac
Ventricular Fibrillation ... with preserved atrial ... #VFib #Ventricular ... echocardiogram #cardiology ... #clinical #a4c
Ventricular Fibrillation on POCUS Echocardiogram - Subcostal 4 Chamber

50's male witnessed arrest. Unknown hx. AED no
Ventricular Fibrillation ... getting 12 lead ECG ... #S4C #POCUS #Echocardiogram ... #ultrasound #Cardiology ... #clinical
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Obtain EKG if: ... CV disease - Arrhythmia ... Change in clinical ... one post op Cardiology ... CARP, DECREASE V trials